Impacts of a comprehensive tuberculosis control model on the quality of clinical services and the financial burden of treatment for patients with drug-resistant tuberculosis in China: a mixed-methods evaluation

Table 1 Key indicators for evaluating the quality of clinical service for drug-resistant TB patients

Area of clinical quality	Indicator
Screening and diagnosis	a. The percentage of bacteriologically positive TB patients ever taking DST
Screening and diagnosis	b. The percentage of bacteriologically positive TB patients ever taking molecular DST
Treatment status	c. The percentage of patients included in treatment
Treatment status	d. The percentage of patients under treatment at the end of 6th months’ treatment among those treated
Rationality and outcome of treatment	e. The percentage of patients taking culture test after 6 months’ treatment
	f. The case negative rate among those taking culture test after 6 months’ treatment
	g. The proportion of rational regimen of all examined medical records

ISSN: 2049-9957